Review on Various Type of Vaccines for Controlling Infectious Disease

Anamika; Sakshi Khanka; Geetika Chandra; Kritika Singh; Deepshikha Jamloki; Farha Naaz; Bhavya Gupta

doi:10.55544/jrasb.3.5.28

Authors

Anamika Research Scholar, Maharaja Agrasen University Baddi, Solan, Himachal Pradesh, INDIA.
Sakshi Khanka Assistant Professor, Department of Pharmacy, Kingston Imperial Institute of Technology and Sciences Dehradun, INDIA.
Geetika Chandra Assistant Professor, Department of Pharmacy, Kingston Imperial Institute of Technology and Sciences Dehradun, INDIA.
Kritika Singh Assistant Professor, Department of Pharmacy, Kingston Imperial Institute of Technology and Sciences Dehradun, INDIA.
Deepshikha Jamloki Assistant Professor, Department of Pharmacy, Shree Dev Bhoomi Institute of Education Science and Technology (SDBIT), Dehradun, INDIA.
Farha Naaz Assistant Professor, Department of Pharmacy, Shree Dev Bhoomi Institute of Education Science and Technology (SDBIT), Dehradun, INDIA.
Bhavya Gupta Research Scholar, Department of Pharmacology, GRDPGIMT, Dehradun, INDIA.

DOI:

https://doi.org/10.55544/jrasb.3.5.28

Keywords:

Vaccines, Infectious disease, COVID-19, Nanoparticle

Abstract

Background: Vaccines have played a critical role in the prevention and treatment of infectious diseases, greatly lowering worldwide morbidity and mortality. This review examines many forms of vaccinations. In contrast, inactivated vaccines, such as the polio vaccine, are safer for immunocompromised people, they frequently require booster shots. Aim: This review emphasises the importance of vaccinations in public health and the need for innovation to tackle future infectious disease threats. The introduction of new pathogens has prompted the creation of novel vaccination platforms, including mRNA and viral vector vaccines. mRNA vaccines, such as those used to treat COVID-19, use genetic instructions to direct cells to manufacture antigens, resulting in strong immunity. Conclusion: These vaccines have demonstrated excellent efficacy and rapid scaling, making them valuable instruments in pandemics. This review emphasises the necessity of designing vaccine methods that meet individual illnesses, demographics, and logistical obstacles. While vaccinations have considerably reduced the occurrence of infectious diseases, more research is needed to address future threats, improve vaccine efficacy, and overcome obstacles such as vaccine reluctance and global inequities. Understanding the capabilities and limits of each vaccine type will help researchers and policymakers better equip healthcare systems to address current and future infectious disease concerns.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Kumar, R., Saha, P., Kumar, Y., Sahana, S., Dubey, A., & Prakash, O. (2020). A review on diabetes mellitus: type1 & Type2. World Journal of Pharmacy and Pharmaceutical Sciences, 9(10), 838-850.

Kumar, R., Saha, P., Lokare, P., Datta, K., Selvakumar, P., & Chourasia, A. (2022). A systemic review of Ocimum sanctum (Tulsi): Morphological characteristics, phytoconstituents and therapeutic applications. International Journal for Research in Applied Sciences and Biotechnology, 9(2), 221-226.

Kumar, R., & Saha, P. (2022). A review on artificial intelligence and machine learning to improve cancer management and drug discovery. International Journal for Research in Applied Sciences and Biotechnology, 9(3), 149-156.

Daharia, A., Jaiswal, V. K., Royal, K. P., Sharma, H., Joginath, A. K., Kumar, R., & Saha, P. (2022). A Comparative review on ginger and garlic with their pharmacological Action. Asian Journal of Pharmaceutical Research and Development, 10(3), 65-69.

Dubey, A., Yadav, P., Verma, P., & Kumar, R. (2022). Investigation of proapoptotic potential of ipomoea carnea leaf extract on breast cancer cell line. Journal of Drug Delivery and Therapeutics, 12(1), 51-55.

Bind, A., Das, S., Singh, V. D., Kumar, R., Chourasia, A., & Saha, P. (2020). Natural bioactives for the potential management of gastric ulceration. Turkish Journal of Physiotherapy and Rehabilitation, 32(3), 221-226.

Saha, P., Nyarko, R. O., Lokare, P., Kahwa, I., Boateng, P. O., & Asum, C. (2022). Effect of Covid-19 in Management of Lung Cancer Disease: A Review. Asian Journal of Pharmaceutical Research and Development, 10(3), 58-64.

Saha, P. (2020). Evolution of tolbutamide in the treatment of diabetes mellitus. Diabetes, 2(10).

Saha, P., Kumar, R., Nyarko, R. O., Kahwa, I., & Owusu, P. (2021). Herbal Secondary Metabolite For Gastro-Protective Ulcer Activity With Api Structures.

Nyarko, R. O., Prakash, A., Kumar, N., Saha, P., & Kumar, R. (2021). Tuberculosis a globalized disease. Asian Journal of Pharmaceutical Research and Development, 9(1), 198-201.

Sahana, S. (2020). Purabi saha, Roshan kumar, Pradipta das, Indranil Chatterjee, Prasit Roy, Sk Abdur Rahamat. A Review of the 2019 Corona virus (COVID-19) World Journal of Pharmacy and Pharmaceutical science, 9(9), 2367-2381.

Sahana, S., Kumar, R., Nag, S., Paul, R., Chatterjee, I., & Guha, N. (2020). A Review On Alzheimer Disease And Future Prospects.

Kumar, R., Saha, P., Sarkar, S., Rawat, N., & Prakash, A. (2021). A Review On Novel Drug Delivery System. IJRAR-International Journal of Research and Analytical Reviews (IJRAR), 8(1), 183-199.

Nyarko, R. O., Kumar, R., Sharma, S., Chourasia, A., Roy, A., & Saha, P. (2022). Antibacterial Activity of Herbal Plant-Tinospora Cordifolia And Catharnthus Roseus.

Ghattas M, Dwivedi G, Lavertu M, Alameh MG. Vaccine technologies and platforms for infectious diseases: Current progress, challenges, and opportunities. Vaccines. 2021 Dec 16;9(12):1490.

Rodrigues CM, Plotkin SA. Impact of vaccines; health, economic and social perspectives. Frontiers in microbiology. 2020 Jul 14;11:1526.

elochukwu ic, okoro o, unekwe p, irinmwinuwa e. role of vaccines in prevention of diseases: a review.

Berkeley S. improving access to vaccine through tiered piercing. Lancet 383, 2018: :2256-2267.

Saleh A, Qamar S, Tekin A, Singh R, Kashyap R. Vaccine development throughout history. Cureus. 2021 Jul;13(7).

Wever PC, van Bergen L. Prevention of tetanus during the First World War. Med Humanit. 2012;38(2):78-82.

Rappuoli R, Malito E. History of Diphtheria Vaccine Development. Corynebacterium diphtheriae and Related Toxigenic Specie. Springer; 2014. p. 225-38.

Tahamtan A, Charostad J, Shokouh SJ, Barati M. An overview of history, evolution, and manufacturing of various generations of vaccines. Journal of Archives in Military Medicine. 2017 Sep 30;5(3).

Conceição Silva F, De Luca PM, Lima-Junior JD. Vaccine development against infectious diseases: state of the art, new insights, and future directions. Vaccines. 2023 Oct 25;11(11):1632.

Kumar R. New trends in vaccine characterization, formulations, and development. Vaccines. 2024 Mar 20;12(3):338.

Shapiro CG, Kendrick P, Grace E. Pertussis vaccines emerging infectious; Journal of medicine, 339(4), 2010; 209-215.

Lotfi H, Mazar MG, Ei NM, Fahim M, Yazdi NS. Vaccination is the most effective and best way to avoid the disease of COVID‐19. Immunity, Inflammation and Disease. 2023 Aug;11(8):e946.

Mak T.W., Saunders M.E. 23—Vaccines and Clinical Immunization. In: Mak T.W., Saunders M.E., editors. The Immune Response. Academic Press; Burlington, MA, USA: 2006. pp. 695–749.

Nooraei S., Bahrulolum H., Hoseini Z.S., Katalani C., Hajizade A., Easton A.J., Ahmadian G. Virus-like Particles: Preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers. J. Nanobiotechnology. 2021;19:59.